Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Anhui Anke Biotechnology (Group) (300009 CH)
Watchlist
16
Analysis
Health Care
•
China
Anhui Anke Biotechnology (Group) Company Ltd. develops, manufactures and markets pharmaceuticals and health-care products including genetic and cellular engineering research and products.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
VISEN Pharmaceuticals
•
19 Oct 2023 08:55
Pre-IPO VISEN Pharmaceuticals - The Product Pipeline and the Key Risks
VISEN’s pipeline has strength, but fierce competition/VBP/increasingly stringent regulatory environment will bring challenges to...
Xinyao (Criss) Wang
Follow
408 Views
Share
bullish
•
Quantitative Analysis
•
03 Feb 2023 08:05
Northbound Flows Monthly: $21bn Inflows in January
We analyzed the Shanghai/Shenzhen Connect Scheme for January and highlight flows for CATL, Moutai, Ping An Insurance, Longi Green, Wuliangye.
Ke Yan, CFA, FRM
Follow
435 Views
Share
bearish
•
Anhui Anke Biotechnology (Group)
•
03 Feb 2022 09:00
Anke Biotechnology (300009CH) Vs Changchun High & New Tech (000661CH)-Growth Hormone VBP and Outlook
We analyzed the impact and outlook of growth hormone VBP that led to share price plunge of Anke and CCHT. We also analyzed the bidding strategy for...
Xinyao (Criss) Wang
Follow
194 Views
Share
bearish
•
Thematic (Sector/Industry)
•
23 Jan 2022 09:15
China Healthcare Weekly (Jan.21)-Growth Hormone VBP,Biotech Survival,Internationalization Conditions
We analyzed the impact of growth hormone/blood products VBP; the "reconsideration" of biotech IPO in primary market, survival problem of listed...
Xinyao (Criss) Wang
Follow
264 Views
Share
bearish
•
Thematic (Sector/Industry)
•
18 Oct 2021 08:51
China Healthcare Weekly (Oct15)-Growth Hormone VBP, Biotech's Business Model,Innovative Drug Outlook
The article analyzed the VBP on recombinant human growth hormone, the difference in business model of big pharma/biopharma and biotech, and the...
Xinyao (Criss) Wang
Follow
208 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x